Study of β-thalassemia biomarkers and their relationship to cognition among children

Ghaydaa A Shehata1, Khaled I Elsayh, Nafisa H Rafet

  • 1Department of Neurology, Assiut University, Egypt. ghaydaa83@yahoo.com

Insights

Beta-thalassemia in children is linked to altered biomarkers like ferritin and nitric oxide. These changes correlate with cognitive function and event-related potentials, impacting brain activity.

Area of Science:

  • Pediatric Hematology
  • Neuroscience
  • Biochemistry

Background:

  • Beta-thalassemia is a genetic blood disorder requiring lifelong management.
  • Cognitive deficits are increasingly recognized in children with beta-thalassemia.
  • Biomarkers may offer insights into disease impact on neurocognition.

Purpose of the Study:

  • To measure beta-thalassemia biomarkers: ferritin, serum transferrin receptors (sTfR), and nitric oxide (NO).
  • To investigate the relationship between these biomarkers and cognitive functions in children.
  • To assess event-related potentials (ERPs) as indicators of cognitive processing.

Main Methods:

  • Comparative study of 30 children with beta-thalassemia and 40 healthy controls.
  • Clinical and laboratory assessments including ferritin, sTfR, and NO levels.
  • Cognitive function tests and event-related potential (ERP) analysis (P300-N2 amplitude).

Main Results:

  • Children with beta-thalassemia showed higher ferritin and sTfR, and lower NO levels.
  • Significant correlations were found between sTfR, NO levels, and ERP latencies/P300-N2 amplitude.
  • Frequent blood transfusions correlated with elevated sTfR and reduced NO.

Conclusions:

  • Biomarker profiles (ferritin, sTfR, NO) are altered in pediatric beta-thalassemia.
  • These biomarkers are associated with cognitive function and neurophysiological measures.
  • Findings suggest potential links between iron overload, NO deficiency, and cognitive impairment in beta-thalassemia.

Related Concept Videos